|
CACNA1S
(HGNC:1397)
|
malignant hyperthermia, susceptibility to, 5
(MONDO_0011163)
|
Moderate
|
|
|
CACNA1S
(HGNC:1397)
|
hypokalemic periodic paralysis
(MONDO_0008223)
|
Definitive
|
|
|
CACNA1H
(HGNC:1395)
|
hyperaldosteronism, familial, type IV
(MONDO_0014875)
|
Moderate
|
|
|
CACNA1H
(HGNC:1395)
|
childhood absence epilepsy
(MONDO_0010826)
|
Limited
|
|
|
CACNA1G
(HGNC:1394)
|
neurodevelopmental disorder
(MONDO_0700092)
|
Moderate
|
|
|
CACNA1G
(HGNC:1394)
|
spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits
(MONDO_0060758)
|
Strong
|
|
|
CACNA1G
(HGNC:1394)
|
spinocerebellar ataxia type 42
(MONDO_0014776)
|
Strong
|
|
|
CACNA1G
(HGNC:1394)
|
intellectual disability
(MONDO_0001071)
|
Limited
|
|
|
CACNA1F
(HGNC:1393)
|
inherited retinal dystrophy
(MONDO_0019118)
|
Strong
|
|
|
CACNA1F
(HGNC:1393)
|
cone-rod dystrophy
(MONDO_0015993)
|
Moderate
|
|
|
CACNA1F
(HGNC:1393)
|
Aland island eye disease
(MONDO_0010371)
|
Moderate
|
|
|
CACNA1F
(HGNC:1393)
|
X-linked cone-rod dystrophy 3
(MONDO_0010335)
|
Moderate
|
|
|
CACNA1F
(HGNC:1393)
|
congenital stationary night blindness 2A
(MONDO_0010241)
|
Definitive
|
|
|
MPIG6B
(HGNC:13937)
|
thrombocytopenia, anemia, and myelofibrosis
(MONDO_0044316)
|
Moderate
|
|
|
CACNA1C
(HGNC:1390)
|
Brugada syndrome
(MONDO_0015263)
|
Moderate
|
|
|
CACNA1E
(HGNC:1392)
|
neurodevelopmental disorder
(MONDO_0700092)
|
Strong
|
|
|
CACNA1C
(HGNC:1390)
|
Timothy syndrome
(MONDO_0010979)
|
Strong
|
|
|
CACNA1C
(HGNC:1390)
|
long QT syndrome
(MONDO_0002442)
|
Moderate
|
|
|
CACNA1C
(HGNC:1390)
|
intellectual disability
(MONDO_0001071)
|
Limited
|
|
|
CACNA1C
(HGNC:1390)
|
short QT syndrome
(MONDO_0000453)
|
Limited
|
|